The Global Adhesion Barrier market is expected to grow at a CAGR of 7.1% during the forecasting period (2022-2029).
An adhesion barrier is referred to as a medical implant that is used to reduce abnormal internal damage by performing surgery by splitting the internal tissues and organs. It is used in several surgical procedures, including abdominal, orthopedic, gynecological, reconstructive, cardiovascular, and urological surgeries. Moreover, the adhesion barriers find their most significant application in cardiovascular surgeries to restore the coronary artery. The film and gel formulations of adhesion barriers are majorly used as compared to the liquid formulation.
The rising prevalence of chronic diseases and the rising number of sports-related injuries are some factors that are expected to propel market growth. Moreover, the rising awareness regarding the medical implications of adhesion barriers and the increasing geriatric population is further supporting the growth of the market across the globe.
The rising geriatric population will continue supporting the growth of the market during the forecast period.
The rising ageing population encourages the possibility of diabetes that results in wound infections and chronic ulcers—the increasing application of adhesion barriers for reducing infections driving the adhesion barrier market. Every country has an increasing number and proportion of ageing people in its population across the globe. The ageing population is one of the most significant social transformations of the present scenario. According to the United Nations, people aged over 60 years were recorded to be around 962 million in 2017 worldwide. This number is further expected to get doubled by 2050 and tripled by 2100. The global population with age 60 years and more is growing faster than the population of younger age groups, which in turn, is contributing to the growth of the market across the globe.
An increasing number of injuries is driving the growth of the global market.
The rising number of surgeries for accidental injuries raises the demand for the adhesion barrier. Several surgeries utilize adhesion barriers, such as elective surgery, emergency surgery, exploratory surgery, cosmetic surgery, etc. According to the American Society for Aesthetic Plastic Surgery (ASAPS), surgical procedures estimate for around 60% of healthcare globally, and nonsurgical procedures accounted for around 40% of the total expenditures globally. There were around 17.5 million surgical and minimally invasive cosmetic procedures performed in the US in 2017 that were 17.8 million in 2016, according to the (ASAPS). This, in turn, is further expected to propel the market growth during the forecast period.
COVID-19 Impact Analysis
The outbreak of COVID-19 has certainly impacted the global adhesion barrier market, backed by the decline in surgical procedures worldwide. During March-August 2020, surgical procedures declined rapidly across the globe, which has hampered the sale of adhesion barriers globally. Therefore, the adhesion barrier market is expected to foresee a considerable decline in 2020.
The adhesion barrier market has been classified into synthetic adhesion barriers and natural adhesion barriers based on the product.
The synthetic adhesion barrier segment accounted for the highest market share in the global market.
Synthetic adhesion barriers contributed to the major share in the adhesion barrier market in 2019 and will project a significant CAGR during the forecast period. These adhesion barriers find their prominent use in post-surgical adhesion prevention products. The synthetic adhesion barriers are cost-effective, owing to which the sale of synthetic adhesion barriers is expected to escalate during the forecast period.
Based on the formulation, the adhesion barrier market has been segmented into film formulation, gel formulation, and liquid formulation.
The film Formulation segment dominated the global adhesion barrier market in 2019
Film formulation dominated the adhesion barrier market in 2019 and is expected to retain its position by exhibiting a considerable CAGR during the forecast period. The major factors driving the growth of the segment in the market include the availability of a broad range of film-form adhesion barriers in the market coupled with the strong clinical support assisting the efficacy of these adhesion barriers in the healthcare sector. Moreover, the ease of use is further increasing the adoption of film-form adhesion barriers, especially among surgeons, related to gel- and liquid-form adhesion barriers.
Based on geography, the study analyzes the adhesion barrier market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America leads the global market throughout the forecast period.
North America dominated the global adhesion barrier market and is expected to retain its position during the forecast period. The US contributed over 85.0% to the North American adhesion barrier market in 2019. The increasing prevalence of cardiovascular diseases and treatment for orthopedic conditions contributes to the rise in demand for adhesion barriers in the region. Moreover, key players, such as Becton Dickinson and Company, Baxter International, and Johnson and Johnson, further support the region's adhesion barrier market.
The Asia Pacific is estimated to grow at a considerable growth rate in the adhesion barrier market during the forecast period. This growth can be accredited to high healthcare spending on establishing advanced healthcare infrastructure and supporting medical tourism. Moreover, the rising geriatric population in Southeast Asia and an increasing prevalence of chronic diseases, such as cardiovascular diseases, are augmenting the market growth in the region.
The adhesion barrier market is highly competitive. The key adhesion barrier players contributing to the global market's growth include Baxter International, Johnson & Johnson Services, Inc., Terumo Corporation, W.L. Gore & Associates, CorMatrix Cardiovascular Inc., and AlloSource, Inc. The major players are adopting new product launch and expansion strategies for global growth in the adhesion barrier market. For instance, in February 2020, Baxter International completed its acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million. Seprafilm has a global commercial presence in the U.S., China, Japan, South Korea, and France, among other countries.
Baxter International was established in the year 1931, and it is headquartered in Deerfield, Illinois. Healthcare company that was founded in 1931. The company makes a wide variety of medicines and medical products through its two divisions: health products and renal. Baxter’s hospital products unit manufactures products to deliver fluids and drugs to patients across the continuum of care. These include Intravenous (IV) and other sterile solutions and administration sets, IV nutrition products, infusion pumps, premixed drugs, drug-reconstitution systems, and inhalation anaesthetics. The business also offers products and services regarding drug formulation, pharmacy compounding, and packaging technologies. The company offers general anesthetic agents and critical care drugs, and drug packaging and formulation technologies.
Product Portfolio: The company manufactures numerous products, including Seprafilm.
Get your free sample proposal with a single click!